HBK Investments’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,900
Closed -$358K 816
2021
Q4
$358K Sell
3,900
-9,800
-72% -$1.17M ﹤0.01% 537
2021
Q3
$1.74M Sell
13,700
-25,500
-65% -$3.71M 0.01% 459
2021
Q2
$6.52M Hold
39,200
0.02% 223
2021
Q1
$7.13M Buy
+39,200
New +$9.09M 0.03% 169
2017
Q4
Sell
-100,000
Closed -$3.31M 1128
2017
Q3
$3.31M Buy
+100,000
New +$3.28M 0.02% 342

Other funds holding TDOC

HBK Investments's TDOC Position: Q1 2022 in Review

HBK Investments sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 3,861 shares — an estimated $355K sold.

HBK Investments first reported a position in TDOC in Q1 2021 and held it in 4 quarters. The position peaked at $4.99M in Q2 2021. 679 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • HBK Investments reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • HBK Investments sold 3,861 Teladoc Health shares in Q1 2022, an estimated $355K.
  • HBK Investments first reported a position in Teladoc Health in Q1 2021 and held it in 4 quarters.
  • HBK Investments's Teladoc Health position peaked at $4.99M in Q2 2021.
  • 679 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on HBK Investments's 13F filing for Q1 2022, filed 16 May 2022.